Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kupper

Showing results (221-230 of 262) with videos related to

Pageof 27
Sort By:
Nature Medicine|July 10, 2012
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cellsRahul Purwar, Christoph Schlapbach, Sheng Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2013
TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphomaEmmanuella Guenova, Rei Watanabe, Jessica E Teague, et al.
Nature Communications|May 11, 2016
Skin CD4(+) memory T cells exhibit combined cluster-mediated retention and equilibration with the circulationNicholas Collins, Xiaodong Jiang, Ali Zaid, et al.
The Journal of Experimental Medicine|September 17, 2008
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsRachael A Clark, Susan J Huang, George F Murphy, et al.
Science Immunology|April 22, 2022
Central memory T cells are the most effective precursors of resident memory T cells in human skinTiago R Matos, Ahmed Gehad, Jessica E Teague, et al.
Molecular Cancer Therapeutics|July 22, 2017
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell LymphomaSalvia Jain, Abigail Washington, Rebecca Karp Leaf, et al.
Blood Cancer Journal|April 17, 2025
Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphomaCecilia Larocca, Ai-Tram N Bui, John T O'Malley, et al.
Molecular Cancer Therapeutics|August 8, 2012
Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cellsDe-Kuan Chang, Jianhua Sui, Shusheng Geng, et al.
The Journal of Clinical Investigation|November 15, 2011
Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphomaClara Curiel-Lewandrowski, Hisato Yamasaki, Chuan Ping Si, et al.
Cancer Immunology Research|March 13, 2020
IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant TumorsTian Tian, Serena Lofftus, Youdong Pan, et al.
Pageof 27

Showing results (221-230 of 262) with videos related to

Sort By:
Pageof 27
Nature Medicine|July 10, 2012
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cellsRahul Purwar, Christoph Schlapbach, Sheng Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2013
TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphomaEmmanuella Guenova, Rei Watanabe, Jessica E Teague, et al.
Nature Communications|May 11, 2016
Skin CD4(+) memory T cells exhibit combined cluster-mediated retention and equilibration with the circulationNicholas Collins, Xiaodong Jiang, Ali Zaid, et al.
The Journal of Experimental Medicine|September 17, 2008
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsRachael A Clark, Susan J Huang, George F Murphy, et al.
Science Immunology|April 22, 2022
Central memory T cells are the most effective precursors of resident memory T cells in human skinTiago R Matos, Ahmed Gehad, Jessica E Teague, et al.
Molecular Cancer Therapeutics|July 22, 2017
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell LymphomaSalvia Jain, Abigail Washington, Rebecca Karp Leaf, et al.
Blood Cancer Journal|April 17, 2025
Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphomaCecilia Larocca, Ai-Tram N Bui, John T O'Malley, et al.
Molecular Cancer Therapeutics|August 8, 2012
Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cellsDe-Kuan Chang, Jianhua Sui, Shusheng Geng, et al.
The Journal of Clinical Investigation|November 15, 2011
Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphomaClara Curiel-Lewandrowski, Hisato Yamasaki, Chuan Ping Si, et al.
Cancer Immunology Research|March 13, 2020
IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant TumorsTian Tian, Serena Lofftus, Youdong Pan, et al.
Pageof 27